Transcode Therapeutics Inc
NASDAQ:RNAZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Transcode Therapeutics Inc
NASDAQ:RNAZ
|
US |
|
C
|
Citius Oncology Inc
NASDAQ:CTOR
|
US |
|
H
|
Hut 8 Mining Corp
NASDAQ:HUT
|
CA |
|
M
|
MSA Safety Inc
F:M07
|
US |
|
Electro-Sensors Inc
NASDAQ:ELSE
|
US |
Shareholder Yield
Current shareholder yield for RNAZ is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RNAZ Price
Transcode Therapeutics Inc
| Average Annual Return | -62.28% |
| Standard Deviation of Annual Returns | 46.96% |
| Max Drawdown | -100% |
| Market Capitalization | 5.1m USD |
| Shares Outstanding | 950 000 |
| Percentage of Shares Shorted | 3.9% |
RNAZ Return Decomposition
Main factors of price return
Stock Splits
RNAZ's latest stock split occurred on May 15, 2025
The company executed a 1-for-28 stock split, meaning that for every 28 shares held, investors received 1 new share.
Before the split, RNAZ traded at 0.3467 per share. Afterward, the share price was about 7.65.
The adjusted shares began trading on May 15, 2025. This was stock split number 4 in RNAZ's history, following the previous one in Dec 4, 2024.
